Journal article
A Review of Human Papillomavirus Vaccination and Associated Ethical Concerns
Infection & chemotherapy, v 56(4), pp 432-439
01 Dec 2024
PMID: 39231505
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Since its Fast-Track approval by the Federal Drug Administration, the human papillomavirus (HPV) vaccine has been marked by controversies. Unconfirmed reports of adverse events in both Japan and Denmark led to suspensions of national vaccination programs, which setback the fight against cervical cancer and associated mortality and morbidity. Despite follow-up studies of vaccine adverse reports, additional randomized control trials, and review reports from both the World Health Organization and the European Commission, there is still a great deal of hesitancy around the vaccine. While all three version of the HPV vaccine have been shown to be efficacious and safe, additional ethical dilemmas deserve to be considered as well.
Metrics
1 Record Views
Details
- Title
- A Review of Human Papillomavirus Vaccination and Associated Ethical Concerns
- Creators
- Eric Fu - University of Colorado DenverOzdemir Erdemir - Drexel UniversityKhalil Pathan - Georgetown UniversityMeaghan Brophy - Georgetown UniversityAidan Pettit - Georgetown University
- Publication Details
- Infection & chemotherapy, v 56(4), pp 432-439
- Publisher
- The Korean Society of Infectious Diseases
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- College of Medicine
- Web of Science ID
- WOS:001408049500002
- Scopus ID
- 2-s2.0-85211024701
- Other Identifier
- 991022202507704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
Source: SDGs in the Output
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Infectious Diseases